CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Evaluation for oral use of Ursodeoxycholyl Lysophosphatidylethanolamide (UDCA-LPE): Effective resorption of sodium salt UDCA-LPE
DOI 10.1055/s-0032-1331968
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Chamulitrat, H Gan-Schreier, J Wang, W Xu, N Katava, S Tuma, A Pathil-Warth, W Stremmel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: UDCA-LPE when administered intraperitoneally (i.p.) is cytoprotective in inhibiting liver injury and inflammation in fulminant LPS-induced hepatitis and ameliorating steatosis, inflammation and fibrosis in mouse models of non-alcoholic steatosis hepatitis (NASH). We previously showed that i.p. injected UDCA-LPE was hydrolyzed back to UDCA and LPE. It is questionable whether UDCA-LPE could be an orally…
Zitieren
Zitierempfehlung
W Chamulitrat, H Gan-Schreier, J Wang, W Xu, N Katava, S Tuma, A Pathil-Warth, W Stremmel (2013) Evaluation for oral use of Ursodeoxycholyl Lysophosphatidylethanolamide (UDCA-LPE): Effective resorption of sodium salt UDCA-LPE. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0032-1331968
Mit CareLit weiterarbeiten